06:51 AM EDT, 10/15/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) reported fiscal Q3 adjusted net earnings Tuesday of $2.42 per diluted share, down from $2.66 a year earlier.

Analysts polled by Capital IQ expected $2.21.

Sales for the quarter ended Sept. 29 were $22.47 billion, up from $21.35 billion a year earlier.

Analysts surveyed by Capital IQ expected $22.17 billion.

For the full-year 2024, the company said it now expects adjusted diluted EPS in the range of $9.88 to $9.98, lower than its prior range of $9.97 to $10.07. Analysts polled by Capital IQ expect $9.95.

Separately, Johnson & Johnson ( JNJ ) said its board maintained its quarterly dividend at $1.24 per share, payable Dec. 10 to shareholders of record on Nov. 26.

Shares of the company were up 1.6% in recent Tuesday premarket activity.

Price: 164.14, Change: +2.54, Percent Change: +1.57